Ben Harshbarger

Ben Harshbarger

Consejero General en ASTRIA THERAPEUTICS, INC. .

Fortuna: - $ al 30/04/2024

55 años
Health Technology
Consumer Services
Commercial Services

Origen de la red de primer grado Ben Harshbarger.

EntidadTipo de entidadIndustria
Public Company Pharmaceuticals: Major 79
Subsidiary Pharmaceuticals: Major 24
Extinct Pharmaceuticals: Major 23
Holding Company Pharmaceuticals: Major 22
Public Company Pharmaceuticals: Major 19
18
Private Company Miscellaneous Commercial Services 18
16
Subsidiary Medical Specialties 16

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Ben Harshbarger a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
Biotechnology

Thomas F. Keller

Ken Bate

Craig Eric Schneier

Lawrence C. Best

Burt Adelman

Sylvie Grégoire

Peter Kellogg

Hans-Peter Hasler

Elan Ezickson

Robert A. Hamm

Steven Perrin

Director/Board Member

Director of Finance/CFO

Human Resources Officer

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

College/University

William Rastetter

Pratik Multani

Jill Milne

Hugh Cole

William T. Andrews

Gilmore O’Neill

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

Anne Cook

William Rastetter

William Young

Peter Kellogg

Hans-Peter Hasler

Paul Clancy

General Counsel

Chairman

Director/Board Member

Director of Finance/CFO

Chief Operating Officer

Director of Finance/CFO

Medical Specialties

Marc Beer

Alison Lawton

Roger W. Louis

Michael Panzara

Andrew Komjathy

Corporate Officer/Principal

Corporate Officer/Principal

Compliance Officer

Corporate Officer/Principal

Sales & Marketing

College/University

Thomas F. Keller

Gregg Lapointe

Tamara Joseph

Jonathan Violin

Michael E. Markels

Corporate Officer/Principal

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

ARIAD PHARMACEUTICALS, INC. Biotechnology

Michael Gilman

Michael Kishbauch

Steven Perrin

Hugh Cole

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Nicolas Barthelemy

Peter Kellogg

Eric W. Kimble

Christopher Morabito

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Ken Bate

Michael Kishbauch

Peter Kellogg

Hugh Cole

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

RECEPTOS INC Pharmaceuticals: Major

William Rastetter

Peter Kellogg

Mary Szela

Robert Peach

Chief Executive Officer

Director of Finance/CFO

Director/Board Member

Founder

Miscellaneous Commercial Services

Lonnie Moulder

Michael Bonney

Marc Beer

Nancy Simonian

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

CELGENE Biotechnology

William Rastetter

Peter Kellogg

Michael Bonney

Joanne Beck

Chief Executive Officer

Director of Finance/CFO

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

Ken Bate

Nancy Simonian

Hugh Cole

Keri McGrail

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Human Resources Officer

University of Pennsylvania College/University

Kevin Kotler

Andrew Hirsch

Michael Panzara

Donald Stern

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

IMMUNOGEN, INC. Biotechnology

Gregory Perry

Daniel Char

Linda Buono

Joseph J. Kenny

Director of Finance/CFO

General Counsel

Human Resources Officer

General Counsel

Georgetown University Law Center College/University

Donald Stern

Mark Dipaolo

Joseph J. Kenny

Graduate Degree

Graduate Degree

Graduate Degree

Boston College College/University

James Dentzer

Steven Perrin

Timothy D. Hunt

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of California, Berkeley College/University

Nicolas Barthelemy

Michael Gilman

Philip Gotwals

Graduate Degree

Doctorate Degree

Doctorate Degree

College/University

Ted Llana

James Kelly

Jennifer Jackson

Doctorate Degree

Masters Business Admin

Doctorate Degree

Massachusetts Institute of Technology College/University

Michael Gilman

Suzanne Bruhn

William Rastetter

Undergraduate Degree

Doctorate Degree

Corporate Officer/Principal

Medical Specialties

Suzanne Bruhn

Sylvie Grégoire

Andrew Komjathy

General Counsel

President

Corporate Officer/Principal

Babson College College/University

Christopher Guiffre

David J. Aubuchon

Paul Clancy

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Hospital/Nursing Management

Lawrence C. Best

Nancy Simonian

Pratik Multani

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Michigan College/University

John Cox

Mary Weger

Christopher Watt

Masters Business Admin

Graduate Degree

Masters Business Admin

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Michael Bonney

Robert Peach

Jennifer Jackson

Director/Board Member

Corporate Officer/Principal

General Counsel

DIANTHUS THERAPEUTICS, INC. Biotechnology

Lonnie Moulder

Alison Lawton

Jonathan Violin

Chairman

Director/Board Member

Director/Board Member

REPLIGEN CORPORATION Pharmaceuticals: Major

Nicolas Barthelemy

John Cox

Jennifer Jackson

Director/Board Member

Director/Board Member

Corporate Officer/Principal

EDITAS MEDICINE, INC. Biotechnology

Andrew Hirsch

Timothy D. Hunt

Gilmore O’Neill

Director/Board Member

Corporate Officer/Principal

Chief Executive Officer

Tufts University College/University

Anne Cook

Roger W. Louis

Daniel Char

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

TREVENA, INC. Pharmaceuticals: Major

Lonnie Moulder

Mark Corrigan

Jonathan Violin

Chairman

Director/Board Member

Founder

VERASTEM, INC. Biotechnology

David Mitchell

Alison Lawton

Robert Gagnon

General Counsel

Director/Board Member

Director/Board Member

Yale University College/University

Elan Ezickson

Eric S. Hoffman

Pratik Multani

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Boston University College/University

Steven Perrin

Andrea Matthews

Amanda Cray

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

SPYRE THERAPEUTICS, INC. Biotechnology

David Mitchell

Suzanne Bruhn

Alison Lawton

General Counsel

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

William Rastetter

John Dunn

Director/Board Member

Director/Board Member

PROGENICS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Burt Adelman

Michael Kishbauch

Director/Board Member

Director/Board Member

TETRALOGIC PHARMACEUTICALS CORPORATION Pharmaceuticals: Major

Burt Adelman

Michael Kishbauch

Director/Board Member

Director/Board Member

IGNYTA INC Biotechnology

Matthew Onaitis

Pratik Multani

General Counsel

Chief Tech/Sci/R&D Officer

University of Arizona College/University

Michael LaBarre

Ji Young Park

Doctorate Degree

Undergraduate Degree

Medical/Nursing Services

Timothy D. Hunt

Joanne Beck

Chief Executive Officer

Director/Board Member

Pharmaceuticals: Major

Sylvie Grégoire

Patrick Volkert Vink

Director/Board Member

Chairman

Pharmaceuticals: Major

Gregg Lapointe

Jeffrey Hackman

Chief Executive Officer

Chief Operating Officer

Princeton University College/University

Peter Kellogg

Nancy Simonian

Undergraduate Degree

Undergraduate Degree

RAPTOR PHARMACEUTICAL CORP Pharmaceuticals: Major

Gregg Lapointe

Suzanne Bruhn

Chairman

Director/Board Member

Estadísticas

Internacional

Estados Unidos 48
Israel 2
Irlanda 2
Reino Unido 2

Sectorial

Health Technology 29
Consumer Services 16
Commercial Services 4
Finance 3
Health Services 3

Operativa

Director/Board Member 489
Corporate Officer/Principal 255
Independent Dir/Board Member 193
Chairman 100
Director of Finance/CFO 90
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA